Physician profile

Deya J Dafashy

Obstetrics & Gynecology · Pasadena, TX

NPI 1538185780

$7,296.35

in general payments reported to CMS, 2019-2025

45 companies · $389 in 2025

The $389 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).

See the full distribution for Obstetrics & Gynecology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,961.84
Travel and Lodging$1,107.26
Education$212.70

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $1,774.16 2022-2024 Solyx Sis System
Abbvie INC. $876.47 2019-2023 Lo Loestrin Fe
Astellas Pharma US INC $498.17 2021-2025 Veozah, Myrbetriq
Applied Medical Resources Corporation $430.69 2021
Caldera Medical, INC $238.41 2020-2023 Desara
Intuitive Surgical, INC. $212.70 2024
Coloplast Corp $209.04 2019-2021
Femselect INC. $203.98 2023 Enplace
Hologic Sales and Service, LLC $202.62 2019-2023 Acessa Provu System, Coolseal Generator
Biogen, INC. $190.85 2024-2025 Zurzuvae
Coopersurgical, INC. $165.45 2019-2023 Wallach Cryosurgical Equipment
Acessa Health INC. $150.23 2019-2021
Millicent US INC $140.31 2020-2025 Femlyv
Allergan, INC. $138.92 2019-2021
Lupin INC. $137.81 2019-2021
Show all 45 companies
CompanyGeneral paymentsYearsTop products
Mayne Pharma Commercial LLC $134.66 2021-2023
Lilly USA, LLC $121.86 2025 Zepbound
Minerva Surgical, INC $117.07 2019
Exeltis, USA INC. $113.74 2019-2025 Slynd, Nuvessa
Shield Therapeutics INC $100.36 2022-2025 Accrufer
Myovant Sciences INC. $98.36 2021-2022
Therapeuticsmd, INC. $97.36 2019-2021
Organon LLC $95.66 2021-2022
Agile Therapeutics, INC. $77.90 2021-2022
Bayer Healthcare Pharmaceuticals INC. $76.22 2019-2020
Merck Sharp & Dohme LLC $76.05 2020-2022
Evofem Biosciences, INC. $73.19 2021-2022
Pacira Pharmaceuticals Incorporated $66.99 2019-2021
Aspira Women'S Health INC $62.71 2022-2024 Ova1
Cumberland Pharmaceuticals, INC. $48.53 2019-2021
Ethicon US, LLC $47.59 2020-2024 Stratafix, Ethicon, Vistaseal
Axonics, INC. $43.08 2022
Exact Sciences Corporation $36.91 2023 Cologuard Collection Kit
Smith+Nephew, INC. $36.82 2019
Urogen Pharma, INC. $27.09 2023 Jelmyto
Roche Diagnostics Corporation $23.25 2019
Mylan Pharmaceuticals INC. $19.85 2021
Avion Pharmaceuticals $19.23 2021
Amag Pharmaceuticals, INC. $16.80 2019
Duchesnay USA Incorporated $16.60 2019
Optumhealth Care Solutions, LLC $16.59 2023 Zyno Solutions, Vivify Health Care Team Portal
Becton, Dickinson and Company $16.44 2022
Mission Pharmacal Company $16.14 2019
Pfizer INC. $15.43 2019
Azurity Pharmaceuticals, INC. $14.06 2023 Adthyza

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Deya J Dafashy

$7,296.35

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $389 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).

https://glasscript.com/doctor/115234/deya-j-dafashy

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.